Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis

Bibliographic Details
Main Authors:	Salugina SO, Fedorov ES, Alexandrova EN, Novikov AA, Cherkasova MV, Baranov AA, Valogina YA, Nikolaeva TN, Zubova NA
Format:	Article
Language:	English
Published:	BMC 2008-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

Frequency and diagnostic significance of anti-cyclic citrullinated peptide antibodies (ACCP) and anti-modified citrullinated vimentin antibodies (AMCV) in children with early juvenile arthritis
by: S O Salugina, et al.
Published: (2008-12-01)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
by: Laura Gonzalez-Lopez, et al.
Published: (2014-01-01)

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
by: Guseinova D, et al.
Published: (2008-09-01)

THE CLINICAL AND DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN EARLY JUVENILEARTHRITIS
by: S O Salugina, et al.
Published: (2009-06-01)

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis
by: A. S. Avdeeva, et al.
Published: (2014-01-01)

Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
by: Refaat M El Tanawy, et al.
Published: (2015-01-01)

Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Published: (2016-01-01)

Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
by: Ruiz-Ortiz de Arrizabaleta Estíbaliz, et al.
Published: (2011-11-01)

Features of Clinical and Laboratory Parameters in Children with Arthritis, which Have Increased Antibody Titers to Cyclic Citrullinated Peptide and Modified Citrullinated Vimentin
by: I.S. Lebets, et al.
Published: (2013-03-01)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
by: Ahmed Al-Shukaili, et al.
Published: (2012-01-01)

Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis
by: Ishigooka, Nozomi
Published: (2020)

CYCLOSPORIN A IN THERAPY FOR JUVENILE ARTHRITIS
by: E S Fedorov, et al.
Published: (2010-06-01)

Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection
by: Howaida E. Mansour, et al.
Published: (2010-05-01)

Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection
by: Howaida E. Mansour, et al.
Published: (2010-01-01)

Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris
by: Szandra Dalmády, et al.
Published: (2013-01-01)

New Insights into the Evolutionary and Genomic Landscape of Molluscum Contagiosum Virus (MCV) based on Nine MCV1 and Six MCV2 Complete Genome Sequences
by: Tomaž M. Zorec, et al.
Published: (2018-10-01)

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
by: Somayye Norouzi, et al.
Published: (2020-08-01)

Role of anti-mutated citrullinated vimentin antibodies in chronic hepatitis C patients and its relation to HCV associated arthritis
by: Shahira El Fedawy, et al.
Published: (2017-07-01)

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
by: Alireza Sadeghi, et al.
Published: (2017-04-01)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
by: Suad Abdeen, et al.
Published: (2011-03-01)

Gene engineering biological therapy for juvenile arthritis
by: Kh Mikhel's, et al.
Published: (2011-02-01)

Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
by: Miriam Lizette Díaz-Toscano, et al.
Published: (2014-01-01)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
by: Mohamed Hamooda, et al.
Published: (2016-09-01)

Role of cytokine net in regulation of inflammation in different variants of juvenile arthritis
by: E S Fedorov, et al.
Published: (2009-06-01)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
by: Tebo Anne E, et al.
Published: (2012-08-01)

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses
by: Victoria A Brentville, et al.
Published: (2020-06-01)

Retrospective analysis of the course and outcomes of juvenile arthritis in adult patients
by: Svetlana Olegovna Salugina, et al.
Published: (2010-05-01)

COMBINED USE OF ERYTHROCYTE ZINC PROTOPORPHYRINE AND MCV: DIFFERENTIATION OF BETA THALASSEMIA FROM IRON DEFICIENCY ANEMIA
by: H KHOSHAMOOZ, et al.
Published: (2001-12-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
by: Bo Li, et al.
Published: (2008-09-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

Cryptanalysis of Low-Data Instances of Full LowMCv2
by: Christian Rechberger, et al.
Published: (2018-09-01)

Diagnostic significance of MCV, MCH AND NESTROFT in thalassemia minor individuals
by: Naheed Afshan, et al.
Published: (2012-07-01)

Early juvenile arthritis – results of two-year follow up
by: S O Salugina, et al.
Published: (2009-12-01)

Meta-Analysis: Diagnostic Accuracy of Anti-Cyclic Citrullinated Peptide Antibody for Juvenile Idiopathic Arthritis
by: Yan Wang, et al.
Published: (2015-01-01)

Juvenile arthritis-early stage of the disease, factors influensing course and prognosis
by: S O Salugina
Published: (2007-06-01)

Vimentin and Anti Vimentin Antibodies in Chagas' Disease
by: Marilda Savoia Nascimento, et al.
Published: (2018-03-01)

Evaluation of the sensitivity and specificity of MCH and MCV for screening of Beta thalassemia minor
by: Kaveh Tari, et al.
Published: (2018-12-01)

Confirmation of the validity of using birth MCV for the diagnosis of alpha thalassemia trait
by: Akram Mehdi Al-Hilali, et al.
Published: (2009-11-01)

Cryopyrin-associated periodic syndromes (CAPS): report on two cases (Muckle-Wells syndrome (MWS) and CINCA/NOMID)
by: Kuzmina NN, et al.
Published: (2011-09-01)